Regulated information

Get easy access to all the information you need. The documentation center allows you to open, send by e-mail or download any document. Feel free to use the filters and add several documents to your basket.
129 result(s)
29/05/2018
17:47
675.65 KB

 

The Combined Ordinary and Extraordinary General meeting was held on Tuesday May 29, 2018 in Lure, chaired by Etienne Frechin.

23/04/2018
17:45
668.11 KB

The registration document of Vetoquinol relative to fiscal year 2017, including the annual financial report relative to fiscal year 2017, was filed with the Autorité des marchés financiers (“the AMF”) on April 23, 2018. 

12/04/2018
17:55
782.94 KB

Vetoquinol posted Q1 2018 consolidated sales of €87.6 million, up 5.6% like for like and 0.4% as reported, compared to the same period last year. Negative currency impacts of 5.2% were mainly related to the US and Canadian dollars and the Indian rupee. 

15/03/2018
08:27
722.13 KB

At its meeting on March 14, 2018, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the audited 2017 financial statements. 

23/01/2018
18:00
683.47 KB

The Vetoquinol Group posted sales of €352.2 million for the 2017 financial year, up 1.0% like-forlike. After a negative currency impact of 0.5%, mainly linked to the US and Canadian dollars, reported growth amounted to 0.5%.  

12/12/2017
17:45
644.06 KB
December 12, 2017 (Lure, France) - Vetoquinol published its calendar of financial communication for 2018.
13/11/2017
18:20
688.49 KB

Lure and Nancy - November 13, 2017: Vetoquinol, a leading player in the animal health sector, and Plant Advanced Technologies PAT, a plant biotechnology company, announce Vetoquinol’s acquisition of an equity stake in Plant Advanced Technologies PAT. The transaction was carried out via a €500,000 reserved capital increase at a price of €25 per share resulting in the veterinary group holding an equity stake of just over 2% in PAT. 
 

17/10/2017
18:00
695.57 KB

For the third quarter of 2017, the Vetoquinol Group posted sales of €88.3 million, up 5.2% from Q3 2016 at constant exchange rates. Sales of Essential products, driver of the Group’s strategy, came to €41.9 million, up 16.7% like-for-like. All three territories posted strong growth at constant exchange rates, particularly Asia Pacific (10.5%), while Europe and the Americas both recorded 4.1% growth.

27/07/2017
18:02
719.45 KB

At its meeting on July 26, 2017, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the financial statements for the first half of 2017.

27/07/2017
18:00
424.65 KB

Communiqué de mise à disposition  du rapport financier semestriel relatif à l’exercice 2017 

26/04/2017
14:24
670.25 KB

The registration document of Vetoquinol relative to fiscal year 2016, including the annual financial report relative to fiscal year 2016, was filed with the Autorité des marchés financiers ("the AMF") on April 26, 2017.

13/04/2017
17:41
424.57 KB

Consolidated sales for Q1 2017 amounted to €86.1 million, up 0.4% as reported from the same period last year. Sales were boosted by a 1.8% positive currency impact mainly related to non-European currencies. Q1 sales fell 1.4% like-for-like. 

22/03/2017
17:45
439.91 KB

At its meeting on March 22, 2017, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the 2016 financial statements. 

26/01/2017
18:00
424.59 KB

The Vetoquinol Group posted sales of €350.3 million for 2016, representing like-for-like growth of 4.3%. After a negative currency impact of 2.0% mainly linked to the British pound, Canadian dollar and Indian rupee, reported growth amounted to 2.3%.

12/12/2016
18:00
167.27 KB
December 12, 2016 (Lure, France) – Vetoquinol published its calendar of financial communication for 2017.
18/10/2016
17:19
419.37 KB

Vetoquinol posted sales of €257.5 million for the first nine months of 2016, up 2.3% compared to the same period last year. Organic growth for the period came to 4.8%, curbed by a 2.5% negative currency impact. 

29/09/2016
16:29
227.37 KB

The veterinary pharmaceutical company Vetoquinol launches its employer brand. For 83 years, Vetoquinol has been building its future, drawing on relationships of trust with its partners, the development of every employee, and its long-held belief of continuous improvement. Following on from its corporate brand, the company is now positioning itself as a high-quality employer.

28/07/2016
18:15
407.32 KB

Communiqué de mise à disposition  du rapport financier semestriel relatif à l’exercice 2016 

28/07/2016
18:00
429.17 KB

Sales growth across all territories : reference products up 5.0

27/04/2016
11:34
408.88 KB

The Registration document of Vetoquinol relative to fiscal year 2015, including the Annual financial report relative to fiscal year 2014, was filed with the Autorité des marchés financiers (“the AMF”) on April 26, 2016.

Basket
Empty basket

INVESTORS CORNER

Vetoquinol has been listed on the Euronext Paris stock market since November 16th.

Consult the documents of the Meeting

Contact

Composition of the bodies of Corporate Management and Governance

Financial information and key figures: annual, half-year and by sector key figures